Motrin IB
NDC 50580-230, Ibuprofen, tablet, film coated, from Kenvue Brands LLC.
- Product NDC
- 50580-230
- Status
- Listed
- Labeler
- Kenvue Brands LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077349
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50580-230 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN200 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50580-230-01 | 50580023001 | 1 BOTTLE in 1 CARTON (50580-230-01) / 50 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-02 | 50580023002 | 1 BOTTLE in 1 CARTON (50580-230-02) / 60 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-03 | 50580023003 | 1 BOTTLE in 1 CARTON (50580-230-03) / 100 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-04 | 50580023004 | 1 BOTTLE in 1 CARTON (50580-230-04) / 225 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-05 | 50580023005 | 1 BOTTLE in 1 CARTON (50580-230-05) / 300 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-06 | 50580023006 | 1 BOTTLE in 1 CARTON (50580-230-06) / 500 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-07 | 50580023007 | 1 BOTTLE in 1 CARTON (50580-230-07) / 24 TABLET, FILM COATED in 1 BOTTLE |
| 50580-230-08 | 50580023008 | 2 TABLET, FILM COATED in 1 POUCH (50580-230-08) |
| 50580-230-09 | 50580023009 | 50 POUCH in 1 CARTON (50580-230-09) / 2 TABLET, FILM COATED in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50580-230 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50580-230 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50580-230. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.